ASX:VBS (Australia)  
Vectus Biosystems Ltd logo

Vectus Biosystems Ltd

A$ 0.71 (-2.08%) Feb 3
P/E:
At Loss
P/B:
0
Market Cap:
A$ 37.50M ($ 25.96M)
Enterprise V:
A$ 42.23M ($ 29.23M)
Volume:
21.96K
Avg Vol (2M):
40.87K
Volume:
21.96K
Market Cap A$:
37.50M
Market Cap $:
25.96M
PE Ratio:
At Loss
Avg Vol (2-Month):
40.87K
Enterprise Value A$:
42.23M
Enterprise Value $:
29.23M
PB Ratio:
0

Business Description

Description
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.
Name Current Vs Industry Vs History
Cash-To-Debt 0.21
Equity-to-Asset -0.9
Debt-to-Equity -1.7
Debt-to-EBITDA -1.83
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 42.29
9-Day RSI 40.09
14-Day RSI 39.49
6-1 Month Momentum % -3.55
12-1 Month Momentum % -41.58

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.5
Quick Ratio 0.5
Cash Ratio 0.17

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.8
Name Current Vs Industry Vs History
ROA % -86.93
ROIC % -81.83
ROC (Joel Greenblatt) % -710.91
ROCE % -712.74

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -12.81
EV-to-EBITDA -12.88
EV-to-FCF -9.88
Earnings Yield (Greenblatt) % -7.81